Johnson & Johnson sees a risk that Food and Drug Administration (FDA) cuts will slow down medicine approvals. And American ...

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

The company makes compounded versions of weight-loss drugs under an FDA rule that applies when the originals are difficult to obtain. The FDA said it will not take action for 90 days against companies ...

Hims & Hers, one of the most popular telehealth services in the world, is in danger of losing one of its central revenue sources. The U.S. Food and Drug Administration (FDA) removed semaglutide ...

The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

The U.S. is in a severe flu season, and antiviral medications such as Tamiflu can help if you get sick—but it's not recommended for everyone. Here's what you need to know about the medication.

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Breakfast snack packs sold at Kroger and Meijer stores in Michigan have been recalled, the FDA announced. Here's what to know.

We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...